Essex Bio-Technology Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Essex Bio-Technology Limited with three other
pharmaceutical manufacturers in Asia:
Panacea Biotec Ltd
sales of 6.53 billion Indian Rupees [US$102.01 million]
of which 59%
Pulike Biological Engineering Inc
(583.09 million Chinese Renmimbi [US$90.48 million]
of which 93%
was Veterinary Chemicals), and
Walvax Biotechnology Company Limited
based in China
(590.16 million Chinese Renmimbi [US$91.58 million]
of which 38%
was Autonomous Vaccine).
Essex Bio-Technology Limited reported sales of HK$775.66 million (US$99.15 million)
December of 2016.
increase of 18.6%
versus 2015, when the company's sales were HK$654.01 million.
Sales at Essex Bio-Technology Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 265%).
Sales of Sales of Pharmaceutical Products saw an increase
20.7% in 2016, from
HK$602.84 million to HK$727.82 million.
Not all segments of Essex Bio-Technology Limited experienced an increase in sales in 2016:
sales of Other Businesses fell 6.5% to HK$47.85 million.